- Home
- TGB vs SRDX Comparison
TGB vs SRDX Comparison
Compare TGB & SRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGB
- SRDX
- Stock Information
- Founded
- TGB 1966
- SRDX 1979
- Country
- TGB Canada
- SRDX United States
- Employees
- TGB N/A
- SRDX N/A
- Industry
- TGB Precious Metals
- SRDX Medical/Dental Instruments
- Sector
- TGB Basic Materials
- SRDX Health Care
- Exchange
- TGB Nasdaq
- SRDX Nasdaq
- Market Cap
- TGB 584.6M
- SRDX 562.6M
- IPO Year
- TGB N/A
- SRDX 1998
- Fundamental
- Price
- TGB $1.98
- SRDX $39.75
- Analyst Decision
- TGB Strong Buy
- SRDX Hold
- Analyst Count
- TGB 1
- SRDX 4
- Target Price
- TGB $3.50
- SRDX $43.00
- AVG Volume (30 Days)
- TGB 2.5M
- SRDX 177.1K
- Earning Date
- TGB 11-06-2024
- SRDX 01-30-2025
- Dividend Yield
- TGB N/A
- SRDX N/A
- EPS Growth
- TGB 207.78
- SRDX N/A
- EPS
- TGB 0.12
- SRDX N/A
- Revenue
- TGB $425,387,060.00
- SRDX $126,078,000.00
- Revenue This Year
- TGB $18.85
- SRDX $13.75
- Revenue Next Year
- TGB $19.29
- SRDX $13.67
- P/E Ratio
- TGB $17.69
- SRDX N/A
- Revenue Growth
- TGB 39.36
- SRDX N/A
- 52 Week Low
- TGB $1.27
- SRDX $25.17
- 52 Week High
- TGB $3.15
- SRDX $42.44
- Technical
- Relative Strength Index (RSI)
- TGB 43.56
- SRDX 55.78
- Support Level
- TGB $1.95
- SRDX $39.50
- Resistance Level
- TGB $2.11
- SRDX $40.39
- Average True Range (ATR)
- TGB 0.10
- SRDX 0.38
- MACD
- TGB -0.00
- SRDX -0.06
- Stochastic Oscillator
- TGB 27.42
- SRDX 46.67
About TGB Taseko Mines Ltd.
Taseko Mines Ltd is a Canadian mining company. It is principally engaged in the production and sale of metals, as well as related activities, including exploration and mine development, within the province of British Columbia, Canada, and the State of Arizona, the United States. The Gibraltar, Aley, New Prosperity, Yellowhead properties are located in British Columbia whereas Florence copper is in central Arizona.
About SRDX Surmodics Inc.
Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.